<!DOCTYPE html>
<html lang="en" class="no-js" prefix="og: http://ogp.me/ns#">

<!-- Mirrored from www.taisho.co.jp/global/news/ by HTTrack Website Copier/3.x [XR&CO'2014], Sun, 16 Oct 2022 12:07:04 GMT -->
<head>
<meta charset="UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=Edge">
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="format-detection" content="telephone=no">

<title>News | Taisho Pharmaceutical Holdings</title>

<meta name="keywords" content="">

<meta name="description" content="View news releases of Taisho Pharmaceutical Group.">
<meta property="og:title" content="News | Taisho Pharmaceutical Holdings" />
<meta property="og:description" content="View news releases of Taisho Pharmaceutical Group." />

<meta property="og:type" content="article" />
<meta property="og:url" content="index.html" />
<meta property="og:site_name" content="Taisho Pharmaceutical Holdings" />
<meta property="og:image" content="../../shared/img/ogp.png" />
<link rel="stylesheet" type="text/css" href="../shared/css/common.css">
<link rel="stylesheet" type="text/css" href="../shared/css/contents_module.css">
<link rel="stylesheet" type="text/css" href="css/news76d7.css?20220707">
</head>

<body id="newsIndex">
<!-- container -->
<div id="container">
	<!-- header -->
		<header>
		<div id="skipLinkArea" class="forReader">
			<ul>
				<li><a href="#contents">To the text</a></li>
				<li><a href="#globalNav">To main menu</a></li>
				<li><a href="#hdr-menu">To header menu</a></li>
				<li><a href="#footer">To footer menu</a></li>
			</ul>
		</div>
		<div id="header">
			<div id="headerInner">
				<h1><a href="../index.html"><img src="../shared/img/logo_mark.svg" alt="" /><img src="../shared/img/logo.png" alt="Taisho Pharmaceutical Holdings" /></a></h1>
				<nav id="globalArea">
					<dl id="searchArea">
						<dt class="search"><span class="btn"><img src="../shared/img/icn_search.png" alt="Search" /></span></dt>
						<dd>
							<div id="search-section">
								<form name="SS_searchForm" id="SS_searchForm" class="roll" action="https://search.taisho.co.jp/search" method="get" enctype="application/x-www-form-urlencoded">
									<input type="hidden" name="site" value="4L6KNUKF" />
									<input type="hidden" name="charset" value="UTF-8" />
									<input type="hidden" name="design" value="12" />
									<input type="hidden" name="group" value="11" />
									<fieldset>
										<legend>Search</legend>
										<div class="boxSearch">
											<input type="text" name="query" value="" id="SS_searchQuery" maxlength="100" class="search-text" placeholder="What are you looking for?" />
											<input type="image" src="../shared/img/btn_search.png" alt="Search" class="search-btn" />
										</div>
									</fieldset>
								</form>
							</div>
						</dd>
					</dl>
					<dl id="globalNavSet">
						<dt>
							<div><span class="btn">MENU</span><span></span><span></span></div>
						</dt>
						<dd>
							<div>
								<ul id="globalNav">
									<li id="gb-whoweare" class="setDrop"><a href="#gb" class="btnSp btnCat" id="m2ndWhoweare"><span>Who We Are</span></a>
										<div id="gbDrop-whoweare" class="hdr-gbDrop">
											<div class="box m2ndWhoweare">
												<div class="boxInner">
													<div class="ttlArea">
														<p class="sp-dsp-none"><a href="../who_we_are/index.html"><span>Who We Are</span></a></p>
														<p class="sp-dsp-block"><a href="#"><span>Who We Are</span></a></p>
														<div class="btnClose"><span></span></div>
													</div>
													<div class="level1">
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="sp-dsp-block"><a href="../who_we_are/index.html"><span>Who We Are Overview</span></a></li>
																	<li><a href="../who_we_are/at_a_glance.html"><span>At a Glance</span></a></li>
																	<li><a href="../who_we_are/message_from_management.html"><span>Message from Management</span></a></li>
																	<li><a href="../who_we_are/history.html"><span>History</span></a></li>
																	<li><a href="../who_we_are/philosophy.html"><span>Philosophy</span></a></li>
																	<li><a href="../who_we_are/board_members.html"><span>Board Members</span></a></li>
																	<li><a href="../who_we_are/worldwide_locations.html"><span>Worldwide Locations</span></a></li>
																</ul>
															</div>
														</div>
													</div>
												</div>
											</div>
										</div>
									</li>
									<li id="gb-products" class="setDrop"><a href="#gb" class="btnSp btnCat" id="m2ndProducts"><span>Our Products</span></a>
										<div id="gbDrop-products" class="hdr-gbDrop">
											<div class="box m2ndProducts">
												<div class="boxInner">
													<div class="ttlArea">
														<p class="sp-dsp-none"><a href="../our_products/index.html"><span>Our Products</span></a></p>
														<p class="sp-dsp-block"><a href="#"><span>Our Products</span></a></p>
														<div class="btnClose"><span></span></div>
													</div>
													<div class="level1">
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="sp-dsp-block"><a href="../our_products/index.html"><span>Our Products Overview</span></a></li>
																	<li><a href="../our_products/lipovitan_series.html"><span>Lipovitan Series</span></a></li>
																	<li><a href="../our_products/pabron_series.html"><span>Pabron Series</span></a></li>
																	<li><a href="../our_products/riup_series.html"><span>RiUP Series</span></a></li>
																	<li><a href="../our_products/counterpain.html"><span>Counterpain<sup>&reg;</sup></span></a></li>
																	<li><a href="../our_products/tempra.html"><span>Tempra<sup>&reg;</sup></span></a></li>
																	<li><a href="../our_products/hapacol.html"><span>Hapacol</span></a></li>
																	<li><a href="../our_products/dafalgan.html"><span>Dafalgan<sup>&reg;</sup></span></a></li>
																	<li><a href="../our_products/efferalgan.html"><span>Efferalgan<sup>&reg;</sup></span></a></li>
																</ul>
															</div>
														</div>
													</div>
												</div>
											</div>
										</div>
									</li>
									<li id="gb-ir" class="setDrop"><a href="#gb" class="btnSp btnCat" id="m2ndIr"><span>Investors</span></a>
										<div id="gbDrop-ir" class="hdr-gbDrop">
											<div class="box m2ndIr">
												<div class="boxInner">
													<div class="ttlArea">
														<p class="sp-dsp-none"><a href="../investors/index.html"><span>Investors</span></a></p>
														<p class="sp-dsp-block"><a href="#"><span>Investors</span></a></p>
														<div class="btnClose"><span></span></div>
													</div>
													<div class="level1">
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="sp-dsp-block"><a href="../investors/index.html"><span>Investors Overview</span></a></li>
																	<li><a href="../investors/our_business.html"><span>Our Business</span></a></li>
																</ul>
																<ul>
																	<li><a href="../investors/financial_highlights.html"><span>Financial Highlights</span></a></li>
																	<li><a href="../investors/segment_information.html"><span>Segment Information</span></a></li>
																</ul>
															</div>
														</div>
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li><a href="../investors/financial_results.html"><span>Financial Results</span></a></li>
																	<li><a href="../investors/presentations.html"><span>Presentations</span></a></li>
																	<li><a href="../investors/annual_reports.html"><span>Annual Reports</span></a></li>
																</ul>
																<ul>
																	<li><a href="../investors/stock_information.html"><span>Stock Information</span></a></li>
																</ul>
															</div>
														</div>
													</div>
												</div>
											</div>
										</div>
									</li>
									<li id="gb-sustainability" class="setDrop"><a href="#gb" class="btnSp btnCat" id="m2ndSustainability"><span>Sustainability</span></a>
										<div id="gbDrop-sustainability" class="hdr-gbDrop">
											<div class="box m2ndSustainability">
												<div class="boxInner">
													<div class="ttlArea">
														<p class="sp-dsp-none"><a href="../sustainability/index.html"><span>Sustainability</span></a></p>
														<p class="sp-dsp-block"><a href="#"><span>Sustainability</span></a></p>
														<div class="btnClose"><span></span></div>
													</div>
													<div class="level1">
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="sp-dsp-block"><a href="../sustainability/index.html"><span>Sustainability Overview</span></a></li>
																	<li><a href="../sustainability/policy/index.html"><span>Sustainability Policy</span></a></li>
																</ul>
																<ul>
																	<li class="btnLevel2"><a href="#level1"><span>Environment</span></a>
																		<ul class="level2">
																			<li class="first"><a href="#level2"><span>Sustainability</span></a></li>
																			<li class="second"><a href="#level2"><span>Environment</span></a></li>
																			<li class="btnTop"><a href="../sustainability/environment/index.html"><span>Environment <u>Overview</u></span></a></li>
																			<li><a href="../sustainability/environment/policy.html"><span>Policies for Environmental Activities</span></a></li>
																			<li><a href="../sustainability/environment/management.html"><span>Environmental Management</span></a></li>
																			<li><a href="../sustainability/environment/accounting.html"><span>Environmental Accounting</span></a></li>
																			<li><a href="../sustainability/environment/impact.html"><span>Impact of Corporate Activities</span></a></li>
																			<li><a href="../sustainability/environment/objectives_achievements.html"><span>Objectives and Achievements</span></a></li>
																			<li><a href="../sustainability/environment/climate_change.html"><span>Addressing Climate Change</span></a></li>
																			<li><a href="../sustainability/environment/recycling.html"><span>Resource Recycling</span></a></li>
																			<li><a href="../sustainability/environment/pollution.html"><span>Pollution Control</span></a></li>
																			<li><a href="../sustainability/environment/community.html"><span>Community Initiatives</span></a></li>
																			<li><a href="../sustainability/environment/methods_data.html"><span>Methods and Data</span></a></li>
																			<li><a href="../sustainability/environment/reports.html"><span>Environmental Reports</span></a></li>
																		</ul>
																	</li>
																</ul>
															</div>
														</div>
														<div class="boxList">
															<div class="boxListInner">
																<ul>
																	<li class="btnLevel2"><a href="#level1"><span>Social</span></a>
																		<ul class="level2">
																			<li class="first"><a href="#level2"><span>Sustainability</span></a></li>
																			<li class="second"><a href="#level2"><span>Social</span></a></li>
																			<li class="btnTop"><a href="../sustainability/social/index.html"><span>Social <u>Overview</u></span></a></li>
																			<li><a href="../sustainability/social/customers/index.html"><span>Customers</span></a></li>
																			<li><a href="../sustainability/social/partners/index.html"><span>Business Partners</span></a></li>
																			<li><a href="../sustainability/social/employees/index.html"><span>Employees</span></a></li>
																			<li><a href="../sustainability/social/society/index.html"><span>Society</span></a></li>
																		</ul>
																	</li>
																</ul>
																<ul>
																	<li class="btnLevel2"><a href="#level1"><span>Governance</span></a>
																		<ul class="level2">
																			<li class="first"><a href="#level2"><span>Sustainability</span></a></li>
																			<li class="second"><a href="#level2"><span>Governance</span></a></li>
																			<li class="btnTop"><a href="../sustainability/governance/index.html"><span>Governance <u>Overview</u></span></a></li>
																			<li><a href="../sustainability/governance/corporate_governance.html"><span>Corporate Governance</span></a></li>
																			<li><a href="../sustainability/governance/internal_control.html"><span>Internal Control</span></a></li>
																			<li><a href="../sustainability/governance/compliance.html"><span>Compliance</span></a></li>
																			<li><a href="../sustainability/governance/risk_management.html"><span>Risk Management</span></a></li>
																		</ul>
																	</li>
																</ul>
															</div>
														</div>
													</div>
												</div>
											</div>
										</div>
									</li>
								</ul>
								<ul id="menu-sub">
									<li><a href="index.html"><span>News</span></a></li>
									<li><a href="../contact_us/index.html"><span>Contact Us</span></a></li>
								</ul>
							</div>
						</dd>
					</dl>
				</nav>
			</div>
		</div>
	</header>

	<!-- //header -->

<!-- topicPath -->
	<div id="topicPath">
		<div class="boxContentsOuter">
			<div class="boxContents">
				<ul id="topicPathMenu">
										<li class="home"><a href="../index.html" class="catFst"><span>Home</span><span class="boxArw"><span></span></span></a>
						<div class="catFst">
							<ul class="catFst">
								<li><a href="../who_we_are/index.html">Who We Are</a></li>
								<li><a href="../our_products/index.html">Our Products</a></li>
								<li><a href="../investors/index.html">Investors</a></li>
								<li><a href="../sustainability/index.html">Sustainability</a></li>
							</ul>
						</div>
					</li>

					<li class="current"><span><span>News</span></span></li>
				</ul>
			</div>
		</div>
	</div>
	<!-- //topicPath -->

	<main id="contents">
		<section>
			<div class="boxContentsOuter">
				<div class="boxContents">

<h1>News</h1>
					<div class="box-clm2">
						<div class="box mB20">
	<div class="boxLine">
                    <p><strong>Year</strong></p>
						<ul class="list-inline">



<li><a href="2022/index.html" class="arw">2022</a></li>





<li><a href="2021/index.html" class="arw">2021</a></li>





<li><a href="2020/index.html" class="arw">2020</a></li>





<li><a href="2019/index.html" class="arw">2019</a></li>





<li><a href="2018/index.html" class="arw">2018</a></li>





<li><a href="2017/index.html" class="arw">2017</a></li>





<li><a href="2016/index.html" class="arw">2016</a></li>

</ul>

					</ul>
					</div>
						</div>
						<div class="box mB20">
						<div class="boxLine">
                            <p><strong>Category</strong></p>
						<ul class="list-inline">
						<li><a href="products/index.html" class="arw">Products</a></li>
						<li><a href="corporate/index.html" class="arw">Corporate</a></li>
						<li><a href="rd/index.html" class="arw">R&amp;D</a></li>
						<li><a href="general/index.html" class="arw">General</a></li>
						<li><a href="organization/index.html" class="arw">Organization</a></li>
						<li><a href="investors/index.html" class="arw">Investors</a></li>
					</ul>
					</div>
						</div>
					</div>
































































































































































































































































































































































































































































































































































































































































































































































































































































































 




























































































 






















































































 






























 





























































 






























 






























 






























 




























































 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 























































 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 























































 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





























 





















<h2>2022</h2>
<div class="newsArea">
<ul>




<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">September 28, 2022</span>
</dt>
<dd>

<a href="2022/20220928001111.html" class="arw">Notification of Application for Approval to Manufacture and Market Rheumatoid Arthritis Therapy Nanozora® 30mg Autoinjectors for S.C. Injection in Japan</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">September 26, 2022</span>
</dt>
<dd>

<a href="2022/20220926001109.html" class="arw">Notification of Approval to Manufacture and Market Nanozora® 30mg Syringes for S.C. Injection, a Therapy for Rheumatoid Arthritis, in Japan Japan's First NANOBODY® Therapeutic</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">August  5, 2022</span>
</dt>
<dd>

<a href="2022/20220805001083.html" class="arw">Cetylpyridinium chloride hydrate (CPC) confirmed to have an action of inactivating SARS-CoV-2 variants</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  3, 2022</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/121502/00.pdf" class="arw" target="_blank">The 1st Quarter of Fiscal 2022 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  3, 2022</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/121501/00.pdf" class="arw" target="_blank">Reference Data of The 1st Quarter of Fiscal 2022 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">June 29, 2022</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material4/186208/00.pdf" class="arw" target="_blank">Notice Concerning Issuance of Stock Options (Stock Acquisition Rights) <img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 13, 2022</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/117516/00.pdf" class="arw" target="_blank">Financial Statements for Fiscal 2021<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 13, 2022</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/117515/00.pdf" class="arw" target="_blank">Reference Data of Financial Statements for Fiscal 2021<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">April 14, 2022</span>
</dt>
<dd>

<a href="2022/20220414000991.html" class="arw">Former All Blacks players Richard McCaw and Daniel Carter appointed Lipovitan Ambassadors</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  1, 2022</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/111941/00.pdf" class="arw" target="_blank">The 3rd Quarter of Fiscal 2021 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  1, 2022</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/111940/00.pdf" class="arw" target="_blank">Reference Data of The 3rd Quarter of Fiscal 2021 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>








<h2>2021</h2>
<div class="newsArea">
<ul>





<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">December 20, 2021</span>
</dt>
<dd>

<a href="2021/20211220000876.html" class="arw">Data from Japan's First Phase II/III Clinical Trial of NANOBODY® Ozoralizumab for Rheumatoid Arthritis Presented at the 36th Annual Meeting of the Japanese Society for Clinical Rheumatology and Related Research</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">November  9, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/108289/00.pdf" class="arw" target="_blank">The 2nd Quarter of Fiscal 2021 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">November  9, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/108290/00.pdf" class="arw" target="_blank">Reference Data of The 2nd Quarter of Fiscal 2021 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">October 25, 2021</span>
</dt>
<dd>

<a href="2021/20211025000999.html" class="arw">Cetylpyridinium chloride hydrate (CPC) confirmed to have an action inactivating SARS-CoV-2</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">October  8, 2021</span>
</dt>
<dd>

<a href="2021/20211008000843.html" class="arw">Taisho Pharmaceutical appointed as  Premium Global Partner of New Zealand Rugby</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  5, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/104248/00.pdf" class="arw" target="_blank">The 1st Quarter of Fiscal 2021 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  5, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/104249/00.pdf" class="arw" target="_blank">Reference Data of The 1st Quarter of Fiscal 2021 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">June 30, 2021</span>
</dt>
<dd>

<a href="2021/20210630000792.html" class="arw">Taisho and Ancora Bio sign exclusive license agreement for the development, manufacturing, and commercialization of selective vasopressin V1b receptor antagonist, TS-121, worldwide</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">June 29, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material4/162514/00.pdf" class="arw" target="_blank">Notice Concerning Issuance of Stock Options (Stock Acquisition Rights) <img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">June 24, 2021</span>
</dt>
<dd>

<a href="2021/20210624000790.html" class="arw">Taisho Pharmaceutical appointed as Official Supplier of Rugby World Cup France 2023</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">May 14, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material4/159095/00.pdf" class="arw" target="_blank">Notice Concerning the Execution of the Share Exchange Agreement to Make Biofermin Pharmaceutical Co., Ltd. a Wholly-owned Subsidiary of Taisho Pharmaceutical Holdings Co., Ltd.<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 14, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/99389/00.pdf" class="arw" target="_blank">Financial Statements for Fiscal 2020<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 14, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/99388/00.pdf" class="arw" target="_blank">Reference Data<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">March 22, 2021</span>
</dt>
<dd>

<a href="2021/20210322000753.html" class="arw">Notification of Application for Approval to Manufacture and Market Anti-TNFα multivalent NANOBODY® compound (ozoralizumab) in Japan<br>Japan's first NANOBODY® Therapeutic</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">February 22, 2021</span>
</dt>
<dd>

<a href="2021/20210222000734.html" class="arw">Notification of Application for Approval of Manufacturing and Marketing for Orally Disintegrating Films of SGLT2 Inhibitor Lusefi® Tablets</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  4, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/94295/00.pdf" class="arw" target="_blank">The 3rd Quarter of Fiscal 2020 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  4, 2021</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/94294/00.pdf" class="arw" target="_blank">Reference Data<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company 
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">January 22, 2021</span>
</dt>
<dd>
 
<a href="2021/2021012201-e.pdf" target="_blank" class="arw">Taisho and Chugai Terminate the Co-Marketing Agreement of Edirol®,a Treatment for Osteoporosis<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>








<h2>2020</h2>
<div class="newsArea">
<ul>





<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 29, 2020</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/88289/00.pdf" class="arw" target="_blank">The 2nd Quarter of Fiscal 2020 Financial Statements<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 29, 2020</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material_for_fiscal_ym2/88288/00.pdf" class="arw" target="_blank">Reference Data<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">August 31, 2020</span>
</dt>
<dd>
 
<a href="2020/2020083101-e.pdf" target="_blank" class="arw">Notice Concerning the Termination of the Agreement Between Taisho Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. on the Distribution of Prescription Drugs of Biofermin Pharmaceutical Co., Ltd.<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  6, 2020</span>
</dt>
<dd>




<a href="https://ssl4.eir-parts.net/doc/4581/ir_material4/145111/00.pdf" class="arw" target="_blank">Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_blank_blue.svg" alt="New window icon" width="14" height="14" class="imgIconBlank"></a>


</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">June 26, 2020</span>
</dt>
<dd>
 
<a href="../global/news/2020/20200626_so-e.pdf" target="_blank" class="arw">Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 14, 2020</span>
</dt>
<dd>
 
<a href="2020/20200514_fn01-e.pdf" target="_blank" class="arw">Financial Statements for Fiscal 2019<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 14, 2020</span>
</dt>
<dd>
 
<a href="2020/20200514_fn02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">April 30, 2020</span>
</dt>
<dd>

<a href="2020/20200430000573.html" class="arw">Taisho and BioAge sign exclusive license agreement for the development, manufacturing, and commercialization of hypoxia inducible factor-prolyl hydroxylase (HIF-PH) inhibitor, TS-143, worldwide</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February 14, 2020</span>
</dt>
<dd>
 
<a href="2020/2020d3_01-e.pdf" target="_blank" class="arw">Financial Statements for the 3rd Quarter of Fiscal 2019<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February 14, 2020</span>
</dt>
<dd>
 
<a href="2020/2020d3_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February 14, 2020</span>
</dt>
<dd>
 
<a href="2020/2020021403-e.pdf" target="_blank" class="arw">Notice of Revision of Forecasts for the Fiscal Year Ending March 31, 2020<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">January 30, 2020</span>
</dt>
<dd>
 
<a href="2020/2020013001-e.pdf" target="_blank" class="arw">Notice of Postponement of Announcement of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2020<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>








<h2>2019</h2>
<div class="newsArea">
<ul>





<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 30, 2019</span>
</dt>
<dd>
 
<a href="2019/2020m_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 30, 2019</span>
</dt>
<dd>
 
<a href="2019/2020m_01-e.pdf" target="_blank" class="arw">Financial Statements for the 2nd Quarter of Fiscal 2019<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnRandD">R&D</span></span>
</div>
<span class="date">October  1, 2019</span>
</dt>
<dd>

<a href="2019/20191001000535.html" class="arw">Taisho and Moberg Pharma sign exclusive license agreement for the development and commercialization of MOB-015 in Japan</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">July 30, 2019</span>
</dt>
<dd>
 
<a href="2019/2019073001-e.pdf" target="_blank" class="arw">Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">July 29, 2019</span>
</dt>
<dd>
 
<a href="2019/2020fq_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">July 29, 2019</span>
</dt>
<dd>
 
<a href="2019/2020fq_01-e.pdf" target="_blank" class="arw">Financial Statements for the 1st Quarter of Fiscal 2019<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">July 29, 2019</span>
</dt>
<dd>
 
<a href="2019/2019072901-e.pdf" target="_blank" class="arw">Notice of Revision of Half-Year and Full-Year Forecasts for the Fiscal Year Ending March 31, 2020<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">July  2, 2019</span>
</dt>
<dd>
 
<a href="2019/2019070201-e.pdf" target="_blank" class="arw">Taisho Completed Procedures for the Acquisition of UPSA SAS<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">June 27, 2019</span>
</dt>
<dd>
 
<a href="2019/2019062701-e.pdf" target="_blank" class="arw">Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">May 20, 2019</span>
</dt>
<dd>
 
<a href="2019/2019052001-e.pdf" target="_blank" class="arw">Duoc Hau Giang Pharmaceutical JSC became a consolidated subsidiary of Taisho<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 13, 2019</span>
</dt>
<dd>
 
<a href="2019/2019fy_rd00-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 13, 2019</span>
</dt>
<dd>
 
<a href="2019/2019fy_00-e.pdf" target="_blank" class="arw">Financial Statements for Fiscal 2018<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 13, 2019</span>
</dt>
<dd>
 
<a href="2019/2019051302-e.pdf" target="_blank" class="arw">Notice Regarding Dividends from Surplus<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 13, 2019</span>
</dt>
<dd>
 
<a href="2019/2019051303-e.pdf" target="_blank" class="arw">Notice of Retirement of Treasury Stock<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">April 18, 2019</span>
</dt>
<dd>
 
<a href="2019/2019041802-e.pdf" target="_blank" class="arw">Notice Regarding the Result of the Tender Offer for Shares of Duoc Hau Giang Pharmaceutical JSC<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">February 28, 2019</span>
</dt>
<dd>
 
<a href="2019/2019022801-e.pdf" target="_blank" class="arw">Notice Regarding the Tender Offer for Shares of Duoc Hau Giang Pharmaceutical JSC<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">January 30, 2019</span>
</dt>
<dd>
 
<a href="2019/2019d3_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">January 30, 2019</span>
</dt>
<dd>
 
<a href="2019/2019d3_01-e.pdf" target="_blank" class="arw">Financial Statements for the 3rd Quarter of Fiscal 2018<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">January 30, 2019</span>
</dt>
<dd>
 
<a href="2019/2019013001-e.pdf" target="_blank" class="arw">Notice of Change in a Sub-subsidiary<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>








<h2>2018</h2>
<div class="newsArea">
<ul>





<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">December 19, 2018</span>
</dt>
<dd>
 
<a href="2018/2018121901-e.pdf" target="_blank" class="arw">Taisho Agreed To Acquire UPSA SAS, A French Pharmaceutical Manufacturer, and its Business Assets, Owned by Bristol-Myers Squibb Company<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 29, 2018</span>
</dt>
<dd>
 
<a href="2018/2019m_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 29, 2018</span>
</dt>
<dd>
 
<a href="2018/2019m_01-e.pdf" target="_blank" class="arw">Financial Statements for the 2nd Quarter of Fiscal 2018<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 23, 2018</span>
</dt>
<dd>
 
<a href="2018/2018102301-e.pdf" target="_blank" class="arw">Notice of Revision of Half-Year Forecasts for the Fiscal Year Ending March 31, 2019<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">October  1, 2018</span>
</dt>
<dd>
 
<a href="2018/2018100101-e.pdf" target="_blank" class="arw">Notice of Termination of Business Alliance with FUJIFILM Holdings Corporation and TOYAMA CHEMICAL CO., LTD. and Change of the System for Sales of Ethical Pharmaceuticals<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">October  1, 2018</span>
</dt>
<dd>
 
<a href="2018/2018100102-e.pdf" target="_blank" class="arw">Notice of Change of Trade Name of Subsidiary<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">August 31, 2018</span>
</dt>
<dd>
 
<a href="2018/2018083101-e.pdf" target="_blank" class="arw">Results of Early Retirement Program<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">August  2, 2018</span>
</dt>
<dd>
 
<a href="2018/2018080202-e.pdf" target="_blank" class="arw">Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  1, 2018</span>
</dt>
<dd>
 
<a href="2018/2019fq_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  1, 2018</span>
</dt>
<dd>
 
<a href="2018/2019fq_01-e.pdf" target="_blank" class="arw">Financial Statements for the 1st Quarter of Fiscal 2018<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">June 28, 2018</span>
</dt>
<dd>
 
<a href="2018/2018062801-e.pdf" target="_blank" class="arw">Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 14, 2018</span>
</dt>
<dd>
 
<a href="2018/2018fy_rd00-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 14, 2018</span>
</dt>
<dd>
 
<a href="2018/2018fy_00-e.pdf" target="_blank" class="arw">Financial Statements for Fiscal 2017<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">May 14, 2018</span>
</dt>
<dd>
 
<a href="2018/2018051401_e.pdf" target="_blank" class="arw">"Notice Concerning Acquisition of Shares in Taisho Toyama Pharmaceutical Co., Ltd. (Conversion into  a Wholly-Owned Subsidiary) and Sale of Shares in TOYAMA CHEMICAL CO., LTD."<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">May 14, 2018</span>
</dt>
<dd>
 
<a href="2018/2018051402_e.pdf" target="_blank" class="arw">Implementation of Early Retirement Program<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  1, 2018</span>
</dt>
<dd>
 
<a href="2018/2018d3_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  1, 2018</span>
</dt>
<dd>
 
<a href="2018/2018d3_01-e.pdf" target="_blank" class="arw">Financial Results for the 3rd Quarter of Fiscal 2017<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>








<h2>2017</h2>
<div class="newsArea">
<ul>





<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company
</span><br>
<span class="boxCategory"><span class="icnGeneral">General</span></span>
</div>
<span class="date">November  1, 2017</span>
</dt>
<dd>

<a href="2017/20171101000499.html" class="arw">Taisho Pharmaceutical Appointed Official Sponsor of Rugby World Cup 2019™ Japan</a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 30, 2017</span>
</dt>
<dd>
 
<a href="2017/2018m_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 30, 2017</span>
</dt>
<dd>
 
<a href="2017/2018m_01-e.pdf" target="_blank" class="arw">Financial Results for the 2nd Quarter of Fiscal 2017<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 25, 2017</span>
</dt>
<dd>
 
<a href="2017/2017102501-e.pdf" target="_blank" class="arw">Notice of Revision of Half-Year Forecasts for the Fiscal Year Ending March 31, 2018<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company 
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">October 13, 2017</span>
</dt>
<dd>
 
<a href="2017/2017101301-e.pdf" target="_blank" class="arw">Transfer of rights to anti-rheumatic agent KOLBET® Tablets in Japan<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">August  3, 2017</span>
</dt>
<dd>
 
<a href="2017/2017080301-e.pdf" target="_blank" class="arw">Notice Concerning Determination of Details of Stock Options<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  2, 2017</span>
</dt>
<dd>
 
<a href="2017/2018fq_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  2, 2017</span>
</dt>
<dd>
 
<a href="2017/2018fq_01-e.pdf" target="_blank" class="arw">Financial Results for the 1st Quarter of Fiscal 2017<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">June 29, 2017</span>
</dt>
<dd>
 
<a href="2017/2017062901-e.pdf" target="_blank" class="arw">Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 15, 2017</span>
</dt>
<dd>
 
<a href="2017/2017fy_rd00-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 15, 2017</span>
</dt>
<dd>
 
<a href="2017/2017fy_00-e.pdf" target="_blank" class="arw">Financial Statements for Fiscal 2016<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  2, 2017</span>
</dt>
<dd>
 
<a href="2017/2017d3_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  2, 2017</span>
</dt>
<dd>
 
<a href="2017/2017d3_01-e.pdf" target="_blank" class="arw">Financial Results for the 3rd Quarter of Fiscal 2016<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">January 31, 2017</span>
</dt>
<dd>
 
<a href="2017/2017013101-e.pdf" target="_blank" class="arw">"Notice Concerning the Termination of the Agreement Between Taisho Pharmaceutical Co., Ltd.  <br>and Takeda Pharmaceutical Co., Ltd. on the Distribution of the OTC Drugs and Quasi-Drugs of  Biofermin Pharmaceutical Co., Ltd."<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>








<h2>2016</h2>
<div class="newsArea">
<ul>





<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">December 26, 2016</span>
</dt>
<dd>
 
<a href="2016/2016122601-e.pdf" target="_blank" class="arw">Notice Concerning Acquisition of Dr. Program Co., Ltd., Consolidated Subsidiary of KYORIN Holdings, Inc.<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnGeneral">General</span></span>
</div>
<span class="date">November 29, 2016</span>
</dt>
<dd>
 
<a href="2016/2016112901-e.pdf" target="_blank" class="arw">Notice of Change in Status of Major Shareholder<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 31, 2016</span>
</dt>
<dd>
 
<a href="2016/2017m_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 31, 2016</span>
</dt>
<dd>
 
<a href="2016/2017m_01-e.pdf" target="_blank" class="arw">Financial Results for the 2nd Quarter of Fiscal 2016<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">October 24, 2016</span>
</dt>
<dd>
 
<a href="2016/2016101901-e.pdf" target="_blank" class="arw">Notice of Revision of Half-Year Forecasts for the Fiscal Year Ending March 31, 2017<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">August  2, 2016</span>
</dt>
<dd>
 
<a href="2016/2016080201-e.pdf" target="_blank" class="arw">Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  1, 2016</span>
</dt>
<dd>
 
<a href="2016/2017fq-02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">August  1, 2016</span>
</dt>
<dd>
 
<a href="2016/2017fq-01-e.pdf" target="_blank" class="arw">Financial Results for the 1st Quarter of Fiscal 2016<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">July 15, 2016</span>
</dt>
<dd>
 
<a href="2016/2016071501-e.pdf" target="_blank" class="arw">Signing of Licensing and Commercialization Agreement Regarding OTC Drug Products in Japan for the Allergy Treatment Claritin<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">July  5, 2016</span>
</dt>
<dd>
 
<a href="2016/2016070501-e.pdf" target="_blank" class="arw">Taisho Completes Acquisition of 24.50% Shares in Duoc Hau Giang Pharmaceutical JSC<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">June 29, 2016</span>
</dt>
<dd>
 
<a href="2016/2016062901-e.pdf" target="_blank" class="arw">Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 16, 2016</span>
</dt>
<dd>
 
<a href="2016/2016fy_rd00-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">May 16, 2016</span>
</dt>
<dd>
 
<a href="2016/2016fy_00-e.pdf" target="_blank" class="arw">Financial Statements for Fiscal 2015<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnProduct">Products</span></span>
</div>
<span class="date">April 21, 2016</span>
</dt>
<dd>
 
<a href="2016/2016042101-e_ttp.pdf" target="_blank" class="arw">Launch of the Agent for Osteoporosis “Bonviva® Tablet 100 mg”<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">March  9, 2016</span>
</dt>
<dd>
 
<a href="2016/2016030901-e.pdf" target="_blank" class="arw">Status of Stock Buyback on Open Market, End of Buyback Program<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">March  1, 2016</span>
</dt>
<dd>
 
<a href="2016/2016030101-e.pdf" target="_blank" class="arw">Status of Stock Buyback on Open Market<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  3, 2016</span>
</dt>
<dd>
 
<a href="2016/2016d3_02-e.pdf" target="_blank" class="arw">Reference Data<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnIR">Investors</span></span>
</div>
<span class="date">February  3, 2016</span>
</dt>
<dd>
 
<a href="2016/2016d3_01-e.pdf" target="_blank" class="arw">Financial Results for the 3rd Quarter of Fiscal 2015<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">February  3, 2016</span>
</dt>
<dd>
 
<a href="2016/2016020301-e.pdf" target="_blank" class="arw">Decision on Matters Concerning Stock Buyback<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Group Company 
</span><br>
<span class="boxCategory"><span class="icnCorporate">Corporate</span></span>
</div>
<span class="date">January 22, 2016</span>
</dt>
<dd>
 
<a href="2016/2016012202-e.pdf" target="_blank" class="arw">Agent for Osteoporosis Approved in Japan “Bonviva® Tablet”<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>











<dl>
<dt>
<div class="boxIcn"><span class="boxCompany">
Holdings
</span><br>
<span class="boxCategory"><span class="icnProduct">Products</span></span>
</div>
<span class="date">January 20, 2016</span>
</dt>
<dd>
 
<a href="2016/2016012001-e.pdf" target="_blank" class="arw">Launch of the Transdermal Anti-inflammatory Analgesic Patch Formulation LOQOA® Tape<img src="../shared/img/icn_pdf.svg" alt="PDF icon" class="imgIconPdf" /></a>

</dd>
</dl>


</ul>

</div>

				</div>
			</div>
		</section>
	</main>
                
<!-- footer -->
	<div id="footerWrap">
	<footer id="footer">
		<div id="footerInner">
			<ul>
				<li><a href="../privacy/index.html">Privacy</a></li>
				<li><a href="../site_policy/index.html">Site Policy</a></li>
				<li><a href="../web_accessibility/index.html">Web Accessibility</a></li>
				<li><a href="../sitemap/index.html">Sitemap</a></li>
			</ul>
			<p class="btn"><a href="https://www.taisho-holdings.co.jp/" target="_blank">Taisho Pharmaceutical Holdings (Japanese)</a></p>
			<p class="copyright">&copy; Taisho Pharmaceutical Holdings Co., Ltd.<span>&nbsp;All Rights Reserved.&nbsp;</span></p>
		</div>
		<div id="ftr-pagetop">
			<div class="boxContents">
				<p><a href="#header"><span>Back to top</span></a></p>
			</div>
		</div>
	</footer>
</div>
	<!-- //footer -->
</div>
<!-- //container -->
<script src="../shared/js/jquery.js"></script>
<script src="../shared/js/common.js"></script>
<script src="../shared/js/analytics.js"></script>
</body>

<!-- Mirrored from www.taisho.co.jp/global/news/ by HTTrack Website Copier/3.x [XR&CO'2014], Sun, 16 Oct 2022 12:07:28 GMT -->
</html>
